Operating Lease, Right-of-Use Asset of Contineum Therapeutics, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Contineum Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Contineum Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,774,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Contineum Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,774,000 +$4,774,000 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $5,007,000 +$4,776,000 +2068% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $5,235,000 +$4,761,000 +1004% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $5,467,000 +$4,748,000 +660% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $0 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $231,000 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $474,000 31 Mar 2024 10-Q 16 May 2024 2024 Q1
Q4 2023 $719,000 31 Dec 2023 10-K 06 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.